Holdings of Nomura Healthcare Fund
Delaware Group Equity Funds IV · 96 declared positions · as of Mar 31, 2026
Original filing · Net assets 665M $ · Ten largest lines: 45.7 % of the equity sleeve
Sector breakdown
- Health care 51.2 %
- Unattributed 48.8 %
Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.
Currency breakdown
- USD 83.4 %
- EUR 8.2 %
- GBP 4.1 %
- JPY 4.0 %
- CHF 0.2 %
The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.
Country breakdown
- US 77.1 %
- BE 6.3 %
- GB 4.2 %
- JP 4.0 %
- FR 2.8 %
- IE 2.3 %
- BM 1.5 %
- NL 0.8 %
- IL 0.4 %
- DE 0.3 %
- KY 0.2 %
- SG 0.1 %
Shares computed on the equity sleeve, the only part this site carries.
| Country | Lines | Value (USD) | Share |
|---|---|---|---|
| US | 76 | 478.5M $ | 77.13 % |
| BE | 1 | 39.2M $ | 6.32 % |
| GB | 2 | 25.8M $ | 4.16 % |
| JP | 1 | 24.8M $ | 4.00 % |
| FR | 4 | 17.3M $ | 2.79 % |
| IE | 3 | 14.2M $ | 2.29 % |
| BM | 1 | 9.4M $ | 1.51 % |
| NL | 2 | 5.2M $ | 0.84 % |
| IL | 2 | 2.2M $ | 0.35 % |
| DE | 1 | 1.6M $ | 0.26 % |
| KY | 1 | 1.5M $ | 0.24 % |
| SG | 1 | 594.2K $ | 0.10 % |
Positions
| Company | Shares | Value (USD) | Weight |
|---|---|---|---|
| UCB SA | 130,137 | 39.2M $ | 5.90 % |
| Regeneron Pharmaceuticals, Inc. | 47,000 | 36.3M $ | 5.46 % |
| Pfizer Inc | 1,145,000 | 32.2M $ | 4.84 % |
| Gilead Sciences Inc | 210,000 | 29.3M $ | 4.40 % |
| AbbVie Inc | 125,000 | 27.2M $ | 4.09 % |
| Merck & Co Inc | 215,000 | 25.9M $ | 3.89 % |
| AstraZeneca PLC | 131,243 | 25.7M $ | 3.86 % |
| Chugai Pharmaceutical Co Ltd | 450,000 | 24.8M $ | 3.73 % |
| Eli Lilly & Co | 26,000 | 23.9M $ | 3.60 % |
| UnitedHealth Group Inc | 70,000 | 18.9M $ | 2.85 % |
| Elevance Health Inc | 63,000 | 18.4M $ | 2.77 % |
| Amgen Inc | 47,000 | 16.5M $ | 2.49 % |
| Viatris Inc | 1,170,018 | 15.8M $ | 2.38 % |
| Boston Scientific Corp | 250,000 | 15.7M $ | 2.36 % |
| Halozyme Therapeutics Inc | 220,000 | 14.2M $ | 2.14 % |
| Sanofi SA | 120,000 | 11.6M $ | 1.74 % |
| Vertex Pharmaceuticals Inc | 25,000 | 11.2M $ | 1.68 % |
| Illumina Inc | 90,000 | 11.1M $ | 1.67 % |
| Viking Therapeutics Inc | 330,100 | 10.7M $ | 1.62 % |
| Alkermes PLC | 290,000 | 10.3M $ | 1.54 % |
| Alnylam Pharmaceuticals Inc | 30,000 | 9.9M $ | 1.49 % |
| Fannie Mae | 1,300,000 | 9.4M $ | 1.42 % |
| Roivant Sciences Ltd | 338,181 | 9.4M $ | 1.41 % |
| Neurocrine Biosciences Inc | 70,000 | 9.2M $ | 1.39 % |
| Cogent Biosciences Inc | 230,000 | 8.9M $ | 1.33 % |
| Arcus Biosciences Inc | 379,100 | 8.2M $ | 1.23 % |
| Incyte Corp | 80,000 | 7.5M $ | 1.13 % |
| Zimmer Biomet Holdings Inc | 80,000 | 7.2M $ | 1.09 % |
| Tarsus Pharmaceuticals Inc | 100,000 | 7M $ | 1.05 % |
| Freddie Mac | 1,050,000 | 6.7M $ | 1.01 % |
| Quest Diagnostics Inc | 30,000 | 5.9M $ | 0.88 % |
| BioMarin Pharmaceutical Inc | 100,000 | 5.6M $ | 0.85 % |
| CVS Health Corp | 75,000 | 5.4M $ | 0.81 % |
| AnaptysBio Inc | 93,732 | 5.2M $ | 0.78 % |
| Biogen Inc | 28,000 | 5.1M $ | 0.77 % |
| Abivax SA | 45,000 | 5M $ | 0.75 % |
| Stryker Corp | 15,000 | 4.9M $ | 0.74 % |
| Johnson & Johnson | 20,000 | 4.9M $ | 0.74 % |
| Vir Biotechnology Inc | 500,000 | 4.5M $ | 0.67 % |
| GRAIL Inc | 85,000 | 4.4M $ | 0.66 % |
| Rigel Pharmaceuticals Inc | 160,000 | 4.3M $ | 0.65 % |
| uniQure NV | 258,211 | 4.2M $ | 0.63 % |
| Syndax Pharmaceuticals Inc | 180,000 | 4.2M $ | 0.63 % |
| Madrigal Pharmaceuticals Inc | 7,000 | 3.7M $ | 0.55 % |
| Theravance Biopharma Inc | 208,783 | 3.4M $ | 0.51 % |
| Monte Rosa Therapeutics Inc | 200,000 | 3.3M $ | 0.49 % |
| Immunovant Inc | 122,100 | 3M $ | 0.46 % |
| Structure Therapeutics Inc | 58,000 | 2.8M $ | 0.42 % |
| Perrigo Co PLC | 230,000 | 2.5M $ | 0.37 % |
| Xencor Inc | 200,000 | 2.4M $ | 0.36 % |
| Day One Biopharmaceuticals Inc | 110,000 | 2.4M $ | 0.35 % |
| Compugen Ltd | 1,020,000 | 2.2M $ | 0.33 % |
| ACADIA Pharmaceuticals Inc | 92,648 | 2.1M $ | 0.31 % |
| Arvinas Inc | 180,000 | 1.9M $ | 0.29 % |
| United Therapeutics Corp | 3,000 | 1.8M $ | 0.27 % |
| BioNTech SE | 18,000 | 1.6M $ | 0.24 % |
| Coherus Oncology Inc | 900,000 | 1.5M $ | 0.23 % |
| MoonLake Immunotherapeutics | 80,000 | 1.5M $ | 0.22 % |
| COSMO Pharmaceuticals NV | 14,000 | 1.5M $ | 0.22 % |
| Ultragenyx Pharmaceutical Inc | 70,000 | 1.5M $ | 0.22 % |
| REGENXBIO Inc | 149,000 | 1.2M $ | 0.19 % |
| Nektar Therapeutics | 17,092 | 1.2M $ | 0.18 % |
| MacroGenics Inc | 420,000 | 1.2M $ | 0.18 % |
| Vaxcyte Inc | 20,000 | 1.2M $ | 0.17 % |
| Janux Therapeutics Inc | 76,601 | 1.1M $ | 0.16 % |
| Moderna Inc | 20,000 | 1M $ | 0.15 % |
| PROQR THERAPEUTICS NV | 620,000 | 1M $ | 0.15 % |
| Cytokinetics Inc | 15,000 | 988.7K $ | 0.15 % |
| Olema Pharmaceuticals Inc | 50,000 | 745.5K $ | 0.11 % |
| Cellectis SA | 226,875 | 719.2K $ | 0.11 % |
| WaVe Life Sciences Ltd | 81,955 | 594.2K $ | 0.09 % |
| Viridian Therapeutics Inc | 29,370 | 574.5K $ | 0.09 % |
| Instil Bio Inc | 50,000 | 412K $ | 0.06 % |
| Puma Biotechnology Inc | 61,255 | 391.4K $ | 0.06 % |
| Atea Pharmaceuticals Inc | 70,000 | 376.6K $ | 0.06 % |
| Allogene Therapeutics Inc | 146,779 | 358.1K $ | 0.05 % |
| Altimmune Inc | 100,000 | 308K $ | 0.05 % |
| Intellia Therapeutics Inc | 20,000 | 256.4K $ | 0.04 % |
| Sarepta Therapeutics Inc | 11,000 | 239.4K $ | 0.04 % |
| Myriad Genetics Inc | 50,000 | 225K $ | 0.03 % |
| Rocket Pharmaceuticals Inc | 58,000 | 207.6K $ | 0.03 % |
| Karyopharm Therapeutics Inc | 33,333 | 185.7K $ | 0.03 % |
| Organon & Co | 29,500 | 176.7K $ | 0.03 % |
| Amarin Corp PLC | 9,500 | 137.4K $ | 0.02 % |
| NextCure Inc | 12,500 | 131.5K $ | 0.02 % |
| XOMA Royalty Corp | 3,466 | 108.7K $ | 0.02 % |
| Sangamo Therapeutics Inc | 400,000 | 98.8K $ | 0.01 % |
| PHIO PHARMACEUTICALS CORP | 50,000 | 61K $ | 0.01 % |
| LITE STRATEGY INC | 30,000 | 34.8K $ | 0.01 % |
| InnoCare Pharma Ltd | 17,000 | 29.6K $ | 0.00 % |
| Voyager Therapeutics Inc | 5,700 | 22K $ | 0.00 % |
| Fortress Biotech Inc | 6,666 | 18.6K $ | 0.00 % |
| Akero Therapeutics Inc | 25,000 | 16.3K $ | 0.00 % |
| Euroapi SA | 8,695 | 13.3K $ | 0.00 % |
| Galmed Pharmaceuticals Ltd | 1,701 | 821.9 $ | 0.00 % |
| MUSTANG BIO INC | 160 | 116.5 $ |